Basic Information
STILAMIN 3000 FOR INJECTION 3 mg/ampoule
INJECTION, POWDER, FOR SOLUTION
Regulatory Information
SIN06135P
June 17, 1991
Prescription Only
Therapeutic
INTRAVENOUS
August 10, 2023
June 3, 2025
XH01CB01
Company Information
Active Ingredients
Strength: 3 mg/ampoule
Detailed Information
Contraindications
**Contraindications** - Known hypersensitivity to somatostatin or any of the excipients of Stilamin® - During pregnancy and the immediate post- partum period (puerperium) as well as during lactation. There is no evidence of the drug’s safety in human pregnancy nor is there evidence from animal work that is free from hazard. Avoid in pregnancy unless there is no safer alternative.
Indication Information
**Indications and use** Stilamin® is indicated for: - Severe acute haemorrhage from oesophageal varices. - Severe acute haemorrhage from gastric or duodenal ulcers, or accompanying acute erosive or haemorrhagic gastritis. - Adjuvant treatment in pancreatic, biliary and intestinal fistulae. - Prophylaxis and treatment of postoperative complications following pancreatic surgery. - Adjuvant treatment in diabetic ketoacidosis.